Literature DB >> 8891836

Malignant pyoderma responding to clofazimine.

T Pari, S George, M Jacob, S M Chandi, S Pulimood, B Rajagopalan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8891836     DOI： 10.1111/j.1365-4362.1996.tb00660.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  6 in total

1.  Segmental ulcerative vasculitis: a cutaneous manifestation of Takayasu's arteritis.

Authors:  Assen L Dourmishev; Dimitrina K Serafimova; Snejina G Vassileva; Lyubomir A Dourmishev; Robert A Schwartz
Journal:  Int Wound J       Date:  2005-12       Impact factor: 3.315

2.  Diagnosis and management of parastomal pyoderma gangrenosum.

Authors:  Xian-Rui Wu; Bo Shen
Journal:  Gastroenterol Rep (Oxf)       Date:  2013-04-19

3.  Nasal septal and mucosal disease associated with pyoderma gangrenosum in a cocaine user.

Authors:  Rahul Sehgal; Jeffrey M Resnick; Ali Al-Hilli; Namrata Mehta; Tyler Conway; Erik J Stratman
Journal:  JAAD Case Rep       Date:  2017-06-22

4.  Superficial Variant of Pyoderma Gangrenosum Successfully Treated with Lower Dose Clofazimine.

Authors:  Alaka J Mohan; Sunitha Balakrishnan; Betsy Ambooken; Kidangazhiathmana Ajithkumar; Neelakandhan Asokan
Journal:  Indian Dermatol Online J       Date:  2022-01-24

Review 5.  Anti-inflammatory and Immunomodulatory Effects of Antibiotics and Their Use in Dermatology.

Authors:  Swetalina Pradhan; Bhushan Madke; Poonam Kabra; Adarsh Lata Singh
Journal:  Indian J Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.494

Review 6.  Multitarget Approaches against Multiresistant Superbugs.

Authors:  Declan Alan Gray; Michaela Wenzel
Journal:  ACS Infect Dis       Date:  2020-03-19       Impact factor: 5.084
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.